MODIFIED GROWTH HORMONE POLYPEPTIDES Russian patent published in 2013 - IPC C07K14/61 C12N15/18 A61K38/27 A61P5/06 

Abstract RU 2471808 C2

FIELD: chemistry.

SUBSTANCE: invention relates to biotechnology, particularly to obtaining a modified growth hormone, and can be used in medicine. By recombination, a polypeptide is obtained, which has antagonistic effect on the growth hormone receptor.

EFFECT: invention enables to obtain a polypeptide which is effective when treating conditions caused by excess growth hormone in the body of the patient.

11 cl, 19 dwg, 2 tbl

Similar patents RU2471808C2

Title Year Author Number
FUSED GROWTH HORMONE PROTEINS 2008
  • Ross Richard
  • Artim'Juk Piter
  • Sehjers Dzhon
RU2473554C2
CHIMERIC POLYPEPTIDE - GROWTH HORMONE RECEPTOR ANTAGONIST, NUCLEIC ACID, EXPRESSION VECTOR, CHIMERIC POLYPEPTIDE APPLICATION (VERSIONS), PHARMACEUTICAL COMPOSITION, CELL, METHOD OF OBTAINING CHIMERIC POLYPEPTIDE AND METHOD OF TREATMENT 2002
  • Ross Richard
  • Sehjers Dzhon
  • Artim'Juk Piter
RU2346047C2
COMBINED PROTEIN INHIBITING RECEPTOR SIGNAL TRANSMISSION OF HORMONE OF GROWTH (VERSIONS), METHOD OF ITS OBTAINING AND CLEARING AND PHARMACEUTICAL COMPOSITION ON ITS BASIS 2002
  • Ross Richard
RU2340628C2
POLYPEPTIDE WITH GROWTH HORMONE RECEPTOR AGONIST PROPERTIES, NUCLEIC ACID CODING SAID POLYPEPTIDE, EXPRESSION VECTOR THEREOF AND CELL PRODUCING SAID POLYPEPTIDE 2005
  • Artimiuk Piter
  • Pradkhananga Sarbendra
  • Sehjers Dzhon
  • Ross Richard
RU2391353C2
NUCLEOTIDE AND AMINO ACID SEQUENCES OF OVICELL FACTORS FOR OVARY FOLLICLE GROWTH CHANGE IN VIVO OR IN VITRO 2001
  • Lajtinen Mika Petri Ehsajas
  • Ritvos Olli Visa-Pekka
  • Dehvis Dzhordzh Genri
  • Gehllouehj S'Juzan Mehj
  • Dzhuendzhel Dzhenni
  • Maknehtti Kennet Pattrik
  • Vuojolajnen Kaisa Niina Jokhanna
RU2270862C2
CHIMERIC FIBROBLAST GROWTH FACTORS WITH CHANGED RECEPTOR SPECIFICITY 2010
  • Sonoda Dzunitiro
RU2573896C2
HUMAN GROWTH HORMONE DERIVATIVE HIGHLY RESISTANT TO PROTEOLYTIC DEGRADATION, METHOD FOR PREPARING THIS DERIVATIVE, USING IT, METHOD OF TREATING, AND PHARMACEUTICAL COMPOSITION 2010
  • Olsen Ole Khvil'Sted
  • Brajnkhol'T Jens
  • S'Edt Kristine Bruun
  • Demjut Khelle
  • Nerskov-Lauritsen Leif
  • Tjugesen Peter
RU2539797C2
MESOTHELINE-TARGETED CANCER VACCINES AND THEIR APPLICATION 2018
  • Yan, Jian
  • Slager, Anna
  • Garman, Bradley
  • Cooch, Neil
RU2751252C1
CHIMERIC PROTEIN, A SYNTHETIC DNA WHICH CODES SAID PROTEIN, AN EXPRESSION VECTOR, A SYNTHETIC DNA PRODUCING STRAIN AND A METHOD OF PRODUCING PLASMID DNA 2016
  • Dukhovlinov Ilya Vladimirovich
RU2736472C2
VIRUS-LIKE PARTICLES COMPOSITION 2013
  • Ueno Ryudzi
  • Akakhata Vataru
RU2705301C2

RU 2 471 808 C2

Authors

Artim'Juk Piter

Ross Richard A.

Sehjers Dzhon

Dates

2013-01-10Published

2008-09-10Filed